PROPRIA LLC
Branford, CT · Founded 2018 · CIK 0001743923 · Medtech · Private
CardioTwin HCM, an engineered heart tissue assay using iPSC-derived cells to measure contractile signatures for hypertrophic cardiomyopathy risk diagnosis.
propriabio.com →- Grants
- $260K
- 1 award
- Sector median: 1
- Raised
- $574K
- 2 Form D · Dec 2019
- 81 months since last filing
- Contracts
- $11K
- 1 award · Veterans Affairs
- #627 of 4531 in medtech
- Patents
- 3
- 2 granted · 1 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20182019202020212022
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $453,000 | |
| Private capital raised | Form D · SEC | $121,000 | |
| Federal contract | Department of Veterans Affairs · Culture & Test Engineered Heart Tissue | $10,900 | |
| Federal grant | Department of Health and Human Services · Phase I · CardioTwin HCM: A non-genetic early diagnostic test for hypertrophic cardiomyopathy risk | $259,609 |
Federal grant · SBIR/STTRFederal contract · USAspendingForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 624 | VULINTUS, INC | $12K | — |
| 625 | Cortechs Labs, Inc. | $12K | $9.1M |
| 626 | MIYAZAKI ENTERPRISES LLC | $11K | — |
| 627 | PROPRIA LLC | $11K | $574K |
| 628 | DuraStat LLC | $11K | $6.8M |
| 629 | Stimlabs LLC | $10K | $10M |
| 630 | CREOSALUS INC. | $10K | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Stuart CampbellDirector
- Stephanie JacobyDirector · Executive Officer
- Bryan WackerExecutive Officer
Patents
- System And Method For Generating And Testing Tissuegranted
- System And Method For Generating And Testing Tissuegranted
- System And Method For Generating And Testing Tissueapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.